I have gathered extensive content from all key references. Now I will compile the comprehensive examination notes.---
HOST-MICROBE INTERACTION IN PERIODONTOLOGY
COMPREHENSIVE THEORY EXAMINATION NOTES
Postgraduate Periodontology - University Examination Level
ABBREVIATIONS USED
GCF = Gingival Crevicular Fluid | PRR = Pattern Recognition Receptor | MAMP = Microbial-Associated Molecular Pattern | PAMP = Pathogen-Associated Molecular Pattern | TLR = Toll-Like Receptor | NLR = NOD-Like Receptor | NF-κB = Nuclear Factor kappa B | RANKL = Receptor Activator of Nuclear Factor kappa B Ligand | OPG = Osteoprotegerin | MMP = Matrix Metalloproteinase | AMP = Antimicrobial Peptide | PMN = Polymorphonuclear neutrophil | DC = Dendritic Cell | ROS = Reactive Oxygen Species | NET = Neutrophil Extracellular Trap
SECTION 1: INTRODUCTION AND CONCEPTUAL OVERVIEW
1.1 Fundamental Concept
- The oral cavity is an important interface with the external environment and is in constant interaction with a great number and variety of microorganisms, mostly organized in plaque biofilms.
- Periodontal disease is currently thought to be driven by a dysbiotic microbiome, in which the nature and dynamic status of host-microbial interactions ultimately dictate the onset and progression of tissue damage observed clinically and radiographically.
- Preclinical research in gnotobiotic animals demonstrates that microorganisms are fundamental for the occurrence of periodontal disease and clinical observations and experimental studies support the rationale for antimicrobial (mechanical and chemical) therapy for the correction of the dysbiotic status and restoring health.
- Substantial experimental evidence supports the concept that host immune response is the primary mediator of periodontal tissue destruction.
(Newman & Carranza's Clinical Periodontology and Implantology, 14th Ed., Chapter 11)
1.2 Recent Conceptual Shift - EXAMINER KEYWORD
- Periodontitis is not, strictly speaking, a bacterial infection. In the classical sense of the term, infections are caused by specific exogenous pathogens and conform, broadly, to Koch's postulates. Periodontitis, on the other hand, is not caused by a single or even a select few bacterial species (traditionally known as periopathogens, the pathogenic role of which could not be confirmed as per Koch's postulates). Rather, the microbial etiology of periodontitis entails synergistic interactions between different indigenous species with distinct roles in a dysbiotic microbial community.
- Destructive inflammation and dysbiosis positively reinforce each other in a self-sustained vicious circle that may contribute to the chronicity of periodontitis.
(Lamont, Hajishengallis, Koo & Jenkinson - Oral Microbiology and Immunology, 3rd Ed., Chapter 15)
SECTION 2: MODELS OF HOST-MICROBE INTERACTION / ETIOLOGIC HYPOTHESES
2.1 Evolution of Plaque Hypotheses (Examiner-Important Sequence)
FLOWCHART:
NON-SPECIFIC PLAQUE HYPOTHESIS (Theilade, 1986)
↓
"Total amount of plaque = disease; no species specificity"
↓
SPECIFIC PLAQUE HYPOTHESIS (Loesche, 1976)
↓
"Certain specific bacteria (not bulk of plaque) determine disease"
↓
ECOLOGICAL PLAQUE HYPOTHESIS (Marsh, 1994)
↓
"Health-associated microbiota + host factors + environmental perturbations
→ Ecological shift → Disease-associated dysbiotic microbiota"
↓
POLYMICROBIAL SYNERGY & DYSBIOSIS MODEL (Hajishengallis & Lamont, 2012)
↓
"Community-wide dysbiosis driven by keystone pathogens; host-microbe
homeostasis disrupted → destructive inflammation → more dysbiosis"
(Newman & Carranza 14th Ed., Chapter 10; Biomarkers in Periodontal Health & Disease, Chapter 2; Lamont et al., 3rd Ed., Chapter 15)
SECTION 3: THE MICROBIAL COMPONENT - VIRULENCE AND PATHOGENICITY
3.1 Criteria for Periodontal Pathogenicity ("Socransky Criteria")
To be considered a periodontal pathogen, an organism should possess an array of virulence factors that can be linked to the pathogenesis of periodontal inflammation. The "Socransky Criteria" were used to generate lists of periodontopathogens in the World Workshop held in 1996. The workshop participants agreed that there is strong evidence for pathogen status of Porphyromonas gingivalis, Tannerella forsythia, and Aggregatibacter actinomycetemcomitans.
(Biomarkers in Periodontal Health & Disease, Chapter 2)
3.2 Microbial Complexes (Socransky et al. 1998)
(Newman & Carranza 14th Ed., Chapter 10)
| Complex | Key Species | Association |
|---|
| Red complex | P. gingivalis, T. forsythia, T. denticola | Strongly associated with periodontitis; "inflammophilic" bacteria |
| Orange complex | F. nucleatum, Prevotella intermedia, P. nigrescens, Campylobacter rectus, Streptococcus constellatus | Bridge between early colonizers and red complex |
| Yellow complex | S. gordonii, S. oralis, S. mitis, S. sanguis | Health-associated early colonizers |
| Green complex | Capnocytophaga spp., A. actinomycetemcomitans serotype a | Moderate virulence |
| Purple complex | Veillonella parvula, Actinomyces odontolyticus | Early colonizers |
| Blue complex | Actinomyces spp. | Health-associated |
3.3 Recent Terminology - Pathobiont Classification
(Essential Microbiology for Dentistry, Samaranayake, 5th Ed., Chapter 17)
| Term | Definition |
|---|
| Consensus periodontal pathogen | Organism with strong evidence of pathogenic role (P. gingivalis, T. forsythia, T. denticola) |
| Keystone pathogen | A microbial species that exerts a disproportionate influence on the structure and function of the microbial community, even at low abundance; disrupts host-microbe homeostasis |
| Pathobiont | A normally commensal microorganism that becomes pathogenic under altered host or microenvironmental conditions |
| Inflammophilic bacteria | Bacteria (red complex) that have co-evolved to endure inflammation and take advantage of it; inflammatory by-products drive their enrichment by providing nutrients in the form of tissue breakdown products (degraded collagen peptides, haem-containing compounds) |
| Accessory pathogen | Species that contributes to virulence of the community (e.g., T. denticola enhancing P. gingivalis virulence) |
(Samaranayake 5th Ed., Chapter 17; Newman & Carranza 14th Ed., Chapter 10)
3.4 Virulence Factors of Key Periodontal Pathogens
(Lamont et al., Oral Microbiology & Immunology, 3rd Ed.; Samaranayake, 5th Ed.)
| Organism | Key Virulence Factors | Host Target/Mechanism |
|---|
| Porphyromonas gingivalis | Fimbriae (FimA, Mfa1); Gingipains (Arg-X, Lys-X cysteine proteases); LPS (atypical); Capsule; HagA hemagglutinin; Fap2 autotransporter; RadD | Adhesion to host cells & interbacterial; destroys immunoglobulins; degrades complement; evades phagocytosis; colonization of placenta |
| Tannerella forsythia | BspA leucine-rich repeat protein; TfsA/TfsB S-layer surface glycoproteins; Sialidase; OmpA-like protein; Endotoxin; Fatty acids; Methylglyoxal | Epithelial cell adhesion/invasion; apoptotic cell death; tissue destruction |
| Treponema denticola | Dentilisin (CTLP complex); OppA; Msp outer sheath protein | Degradation of extracellular matrix; tissue invasion; cleaves bound Factor H |
| Aggregatibacter actinomycetemcomitans | Leukotoxin (LtxA); Cytolethal distending toxin (Cdt); Fimbriae; LPS; Collagenase; Bone resorption factors | Kills PMNs/macrophages; cell cycle arrest; bone resorption |
| Fusobacterium nucleatum | FadA adhesin; RadD; TIGIT ligand Fap2 | Bridge species for polymicrobial biofilm; adhesion to host cells; immunomodulation |
| Prevotella intermedia | Type A, B, C, D fimbriae; Proteases | Adhesion; interspecies binding; hormone responsiveness |
(Lamont et al., 3rd Ed., Chapter on Periodontal Pathogens; Samaranayake, 5th Ed., Chapter 17)
SECTION 4: THE KEYSTONE PATHOGEN HYPOTHESIS
4.1 Definition and Mechanism
- P. gingivalis is considered by some authors as the primary keystone pathogen in periodontitis.
- The keystone pathogen hypothesis has been extended to include the concept of "polymicrobial synergy" and "dysbiosis model" of disease. In this model, interspecies communication between keystone pathogens and other members of the community allows the whole microbial community to become more virulent than its individual parts.
- Keystone pathogens (such as P. gingivalis) play a disproportionately large role in subverting host immunity, thereby promoting dysbiosis and allowing the overgrowth of communities of otherwise relatively non-pathogenic species.
(Newman & Carranza 14th Ed., Chapter 10; Lamont et al., 3rd Ed., Chapter 15)
FLOWCHART - Polymicrobial Synergy & Dysbiosis Model:
Low-abundance KEYSTONE PATHOGEN (e.g., P. gingivalis)
↓
Subverts host innate/complement immunity
↓
Creates permissive environment for entire microbial community
↓
Community-wide DYSBIOSIS (overgrowth of otherwise low-virulence species)
↓
Dysbiotic microbiota provokes dysregulated/excessive HOST INFLAMMATION
↓
Tissue destruction (bone loss, attachment loss)
↓
Tissue breakdown products (peptides, haem) = nutrients → fuel dysbiotic bacteria
↓
VICIOUS CYCLE (dysbiosis ↔ inflammation ↔ more destruction)
(Lamont et al., 3rd Ed., Chapter 15)
4.2 Mechanisms of Immune Subversion by P. gingivalis
(Lamont et al., 3rd Ed.; Newman & Carranza 14th Ed., Chapter 11)
| Mechanism | Detail |
|---|
| Complement C5aR hijacking | P. gingivalis activates C5aR1 via its gingipains, which crosstalk with TLR2 to downregulate IL-12p70 production, impairing microbial clearance |
| C3 inactivation | Gingipains cleave and inactivate C3, evading complement-mediated opsonization |
| Factor H recruitment | T. denticola dentilisin cleaves bound Factor H; P. gingivalis Fap2 binds Factor H to evade alternative complement pathway |
| TLR2 manipulation | P. gingivalis LPS acts as a TLR2 agonist (atypical lipid A), inducing a tolerogenic rather than antimicrobial response; activates pro-inflammatory but immunoevasive signaling |
| Leukocyte escape | Capsule of P. gingivalis defends against phagocytosis; gingipains degrade immunoglobulins |
| Gingipain-mediated cleavage | Destroys cytokines, complement proteins, and immunoglobulins |
SECTION 5: DYSBIOSIS AND ECOLOGICAL PLAQUE HYPOTHESIS
5.1 The Ecological Plaque Hypothesis (Marsh, 1994)
- The principles of this hypothesis are that both the total amount of dental biofilm and the specific microbial composition of biofilms may contribute to the transition from health to disease.
- The health-associated dental microbiota is considered to be relatively stable over time and in a state of dynamic equilibrium or "microbial homeostasis."
- The host controls subgingival biofilms to some extent by a tempered immune response and low levels of GCF flow. Perturbations to the host response may be brought about by:
- Excessive accumulation of nonspecific dental biofilm leading to inflammation
- Biofilm-independent host factors (e.g., immune disorder, hormonal changes, pregnancy)
- Environmental factors (e.g., smoking, diet)
- Changes in host status (inflammation, tissue degradation, high GCF flow) may lead to a shift in the microbial population. This gradual shift in the entire microbial community is known as dysbiosis, which may result in a chronic disease state such as periodontitis.
(Newman & Carranza 14th Ed., Chapter 10)
5.2 Factors That Disrupt Periodontal Homeostasis
(Biomarkers in Periodontal Health & Disease, Chapter 2)
| Host-Related Factors | Microbe-Related Factors | Environmental Factors |
|---|
| Congenital/acquired immunodeficiencies | Keystone pathogens (e.g., P. gingivalis) | Smoking |
| Immunoregulatory defects (mutations/polymorphisms) | Polymicrobial community virulence gene expression | Diet |
| Old age | Specific virulence factor combinations | Psychological stress |
| Systemic diseases (diabetes, obesity) | Biofilm-mediated immune evasion | Epigenetic modifications |
| Epigenetic modifications | Interspecies communication/signaling | Infection |
| Genetic susceptibility | | |
SECTION 6: INNATE IMMUNE RESPONSE IN THE PERIODONTIUM
6.1 First Line - Epithelial Barrier
(Newman & Carranza 14th Ed., Chapters 11 and 15)
- The epithelium provides a physical barrier to impede the ingress of bacteria and their products; disruption of the epithelial barrier can lead to further bacterial invasion and inflammation.
- Antimicrobial Peptides (AMPs), also called defensins, are expressed by epithelial cells:
- Human β-defensins: hBD-1 and hBD-2 (expressed by gingival epithelial cells)
- Cathelicidin: LL-37 (found in lysosomes of neutrophils; also expressed in gingiva)
- These AMPs are important for determining the outcomes of the host-pathogen interactions at the epithelial barrier.
- The epithelium is, therefore, more than simply a passive barrier: it also has an active role in innate immunity.
- Epithelial cells in the junctional and sulcular epithelia are in constant contact with bacterial products and respond by secreting chemokines (e.g., IL-8/CXCL8) to attract neutrophils, which migrate up the chemotactic gradient toward the pocket.
6.2 Pattern Recognition Receptors (PRRs) and MAMPs/PAMPs
(Newman & Carranza 14th Ed., Chapter 11; Lamont et al., 3rd Ed.)
| Term | Definition |
|---|
| MAMPs | Microbial-Associated Molecular Patterns - molecules associated with microorganisms that activate innate immunity through specific signaling pathways |
| PAMPs | Pathogen-Associated Molecular Patterns - molecular structures distinct from self, recognized by the innate immune system (LPS, peptidoglycan, LTA, mannans, bacterial DNA, double-stranded RNA, glucans) |
| DAMPs | Damage-Associated Molecular Patterns - endogenous molecules released from damaged/dying host cells that activate PRRs |
| PRRs | Pattern Recognition Receptors - recognize MAMPs/PAMPs; include TLRs, NLRs, CLRs, RIG-I-like receptors |
Common PAMPs and their PRRs:
| PAMP | Source | Recognizing PRR |
|---|
| Lipopolysaccharide (LPS) | Gram-negative bacteria | TLR4 (with CD14/MD2) |
| Lipoteichoic acid (LTA), lipoproteins, peptidoglycan | Gram-positive bacteria | TLR2 (as heterodimer with TLR1 or TLR6) |
| CpG DNA | Unmethylated bacterial DNA | TLR9 |
| Flagellin | Bacterial flagella | TLR5 |
| dsRNA | Viral dsRNA | TLR3 |
| Peptidoglycan fragments (muramyl dipeptide) | Intracellular bacteria | NOD2 |
| Peptidoglycan fragments (iE-DAP) | Gram-negative bacteria | NOD1 |
(Newman & Carranza 14th Ed., Chapter 11)
6.3 Toll-Like Receptors (TLRs) in Periodontitis
(Newman & Carranza 14th Ed., Chapter 11)
- Functional PRRs are known to be expressed by "non-professional" immune cells (e.g., epithelial cells, fibroblasts, osteoblasts) that have a role in innate immunity, and also by adaptive immune cells.
- TLR signaling pathway:
- Ligand binding → recruitment of adaptor proteins and kinases
- MyD88 is an adaptor protein required for signaling by all TLRs except TLR3 (which signals via TRIF)
- Intracellular (endosome) TLR4 may also signal in a MyD88-independent manner via TRIF
- Downstream of MyD88: IRAK1 → TRAF6 → TAK1 → activation of NF-κB and MAP kinases → induction of pro-inflammatory mediators
- Also activates Inflammasome components (NLRP3) as the "first inflammasome-activating signal"
TLR Signaling Cascade - FLOWCHART:
MICROBIAL LIGAND (LPS, LTA, CpG DNA)
↓
TLR activation (membrane-bound or endosomal)
↓
Adaptor recruitment: MyD88 (all TLRs) / TRIF (TLR3; TLR4 in endosome)
↓
MyD88 pathway TRIF pathway
↓ ↓
IRAK1/4 → TRAF6 → TAK1 IRF3 / IRF7
↓ ↓
IKKβ → NF-κB activation Type I IFN (IFNα/β) genes
↓
MKK → p38, JNK, ERK (MAPKs)
↓
AP-1 activation
↓
Expression of:
• Cytokines (TNF-α, IL-1, IL-6)
• Chemokines (CCL2, CXCL8)
• Endothelial adhesion molecules (E-selectin)
• Costimulatory molecules (CD80, CD86)
• Inflammasome components (NLRP3)
6.4 NOD-Like Receptors (NLRs) in Periodontitis
(Newman & Carranza 14th Ed., Chapter 11)
NOD1 and NOD2 (NLRC Subfamily):
- Cytosolic PRRs that recognize peptidoglycan fragments of the bacterial cell wall
- Can also activate NF-κB and MAPK, signaling via Rip2
- NOD1 recognizes iE-DAP (Gram-negative bacteria); NOD2 recognizes MDP (muramyl dipeptide; broad bacterial recognition)
NLRP3 Inflammasome (NLRP Subfamily):
- NLRP3 Inflammasome activation can be induced by various ligands (DAMPs, ROS, ATP, cathepsins)
- Results in assembly of a multi-protein complex: oligomerization of NLRP3, ASC, and pro-Caspase-1
- Autoproteolytic cleavage of oligomerized pro-caspase-1 → cleaved (active) Caspase-1
- Active Caspase-1 cleaves pro-IL-1β → mature IL-1β (and pro-IL-18 → IL-18)
- Active caspase-1 also cleaves Gasdermin D (GSDMD) → N-GSDMD → membrane pore formation → pyroptosis
- Activated NLRP3 inflammasome is expressed in periodontitis tissues and contributes to IL-1β-mediated alveolar bone resorption
6.5 Role of Complement System
(Newman & Carranza 14th Ed., Chapter 11; Lamont et al., 3rd Ed., Chapter 15)
Three pathways of complement activation:
| Pathway | Trigger | Key Initiating Components |
|---|
| Classical pathway | Antigen-antibody complexes | C1q, C1r, C1s |
| Lectin pathway | Mannose-binding lectin + MASP | MBL, MASP-1/2 |
| Alternative pathway | Direct microbial surface activation (spontaneous C3 hydrolysis) | C3, Factor B, Factor D, Properdin |
- All three pathways converge at C3 (the third component), activated by pathway-specific C3 convertases.
- C3 activation leads to:
- Recruitment and activation of inflammatory cells via anaphylatoxins C3a and C5a (interact with G-protein-coupled receptors on leukocytes)
- Microbial opsonization through opsonins such as C3b to facilitate phagocytosis
- Direct lysis of targeted susceptible bacteria by means of the C5b-9 Membrane Attack Complex (MAC)
Complement and Periodontitis:
- The GCF in the gingival crevice contains a functional complement system. Therefore, the subgingival bacteria likely constantly encounter complement and the generated complement-dependent host defense mechanisms may contribute to host-microbe homeostasis in the healthy periodontium.
- Clinical evidence: Complement activation products are readily detected in chronically inflamed gingivae and the GCF of patients, whereas they are undetectable or present at lower levels in control samples from periodontally healthy individuals.
- Experimental gingivitis in human volunteers causes progressive complement activation (as determined by increased C3 cleavage in GCF), which in turn correlates with increased clinical indices of inflammation. Conversely, successful periodontal therapy leads to decreased C3 activation.
- A cause-and-effect relationship between complement and periodontitis was supported by interventional and mechanistic studies in preclinical models. Specifically, genetic and pharmacological studies in rodents have shown that complement is involved in both the dysbiotic transformation of the periodontal microbiota and in the inflammatory process that leads to the destruction of alveolar bone. The critical involvement of central complement component C3 in periodontal pathogenesis was confirmed in non-human primates, where local administration of a C3 inhibitor drug blocked naturally occurring periodontitis.
Complement-TLR Cross-Talk:
- The concomitant activation of C5aR1 and TLR2 in the gingival tissue of mice after local micro-injection of specific ligands (C5a anaphylatoxin and Pam3Cys lipopeptide, respectively) causes the production of significantly higher levels of pro-inflammatory and pro-osteoclastogenic cytokines (IL-1β, IL-6, IL-17, and TNF) in the gingiva than stimulation of either receptor alone.
- The signaling pathways activated downstream of complement receptors (C3aR or C5aR1) and TLRs (TLR2 or TLR4) converge at MAPKs (ERK1/2 and JNK), which in turn enhance the activation of AP-1 and NF-κB, key transcription factors involved in the induction of inflammatory cytokines.
(Newman & Carranza 14th Ed., Chapter 11)
SECTION 7: CELLS OF THE INNATE IMMUNE RESPONSE
7.1 Neutrophils (PMNs)
(Newman & Carranza 14th Ed., Chapters 11, 15; Lamont et al., 3rd Ed.)
- Neutrophils are key components of the innate immune system and play a fundamental role in maintaining periodontal health, despite the constant challenge presented by the plaque biofilm.
- Transmigrating neutrophils are evident in clinically healthy gingival tissues moving toward the sulcus for the purpose of eliminating bacteria.
- The migration of leukocytes into the crevice occurs through the junctional epithelium, which, under inflammatory conditions, is largely occupied (by about 60%) by trafficking neutrophils.
- Neutrophils are protective leukocytes that phagocytose and kill bacteria; deficiencies in neutrophil functioning result in increased susceptibility to infections in general, as well as periodontal disease.
- Dual role of neutrophils (Pathway #1):
- Beneficial: Phagocytosis, ROS production, degranulation killing bacteria
- Harmful: Release of large quantities of destructive enzymes (MMPs - particularly MMP-8 and MMP-9) as they migrate through the tissues → breakdown of structural components → collagen-depleted areas
- Also release lysosomal enzymes, cytokines, and ROS extracellularly → further collagen depletion and tissue damage
- Patients with periodontitis have neutrophils that demonstrate enhanced enzymatic activity and produce increased levels of ROS.
- Neutrophils can also activate the adaptive immune defense via secretion of CCL2 and CCL20 and in a limited sense increase osteoclastogenesis with membrane-bound RANKL.
- Neutrophil phenotypes:
| Phenotype | Markers | Key Products | Function |
|---|
| N1 (pro-inflammatory) | CD11b+CD16brightCD62Lbright | TNF-α, ROS, IL-1β, IL-6, IL-8, NETs, LL-37, MMP-8/-9, MPO, RANKL | Antimicrobial; tissue destructive potential |
| N2 (tolerogenic/suppressive) | CD11b+CD16brightCD62Ldim | Arginase, CCL2, CCL5, TGFβ, IL-10, MMP-9, TIMP-1 | Immune suppression; tissue remodeling |
- Salivary PMNs (orogranulocytes): PMNs in saliva have interacted with multiple antigens from the microbiome (unlike naive blood PMNs). The orogranulocytic migratory rate positively correlates with the severity of gingival inflammation and is a reliable index for assessment of gingivitis.
7.2 Macrophages
(Newman & Carranza 14th Ed., Chapter 11)
| Phenotype | Markers | Key Products | Function |
|---|
| M1 (classical activation) | CD86+, MHC-IIhigh | IL-1β, IL-6, TNF-α, IL-12, IL-23, ROS, NO | Pro-inflammatory; antimicrobial; antigen presentation via MHC-II |
| M2 (alternative activation) | CD163+, CD206+, MHC-IIlow | IL-1ra, IL-10, VEGF, TGFβ | Angiogenesis; vascular permeability control; repair |
- Participate in host response to microorganisms by phagocytosing, microbial killing, and antigen presentation via MHC-II.
- These cells express functional PRRs and produce inflammatory mediators that stimulate other immune cells.
- Similarly to osteocytes, may support osteoclastic resorption of dental root and alveolar bone.
- In diabetes: Increased M1 macrophages along with additive secretion of TNFα are observed, contributing to immunological dysregulation resulting in elevated inflammation, heightened susceptibility to infection, delayed wound healing, and increased osteoclastogenesis/bone loss/attachment loss.
(Newman & Carranza 14th Ed., Chapter 11)
7.3 Dendritic Cells (DCs) and Langerhans Cells
(Lamont et al., 3rd Ed.)
- Dendritic cells and Langerhans cells internalize bacterial cells, breaking down the component proteins into discrete antigens for presentation to T cells and stimulation of an adaptive immune response.
- Clinically healthy human gingivae contain a network of APCs (dendritic cells and macrophages) that orchestrate local immunity.
- DC-SIGN (C-type lectin on dendritic cells) serves as a receptor for P. gingivalis streptococcal surface proteins SspA/B, mediating adhesion to and invasion of the host.
7.4 Osteoblasts and Osteocytes in Innate Immunity
(Newman & Carranza 14th Ed., Chapter 11)
| Cell Type | Markers | Key Mediators | Role |
|---|
| Osteoblasts | Osteopontin, RUNX2, Osterix, Osteocalcin | IL-1β, IL-6, TNF-α, RANKL, PGE2, NO, MMP-2/-9, OPG | Express functional PRRs; produce inflammatory mediators; can support or inhibit osteoclastic bone resorption |
| Osteocytes | Sclerostin, DMP-1, FGF-23 | IL-1β, IL-6, TNF-α, RANKL, OPG, Sclerostin | Most abundant bone cell; major source of RANKL in the periodontal microenvironment; respond to MAMPs |
| Osteoclasts | RANK+, TRAP+, Cathepsin K+ | MMP-9, IL-1β, IL-6, TNF-α, IL-10, TGFβ | Derived from erythro-myeloid precursors; directly responsible for bone resorption; differentiate in response to RANKL/OPG gradient |
SECTION 8: HISTOPATHOLOGICAL STAGES OF THE GINGIVAL LESION
Page and Schroeder Classification (1976) - EXAMINER CLASSIC
(Newman & Carranza 14th Ed., Chapter 15; Carranza 10th Ed.)
| Stage | Name | Time | Dominant Cell | Key Features |
|---|
| Stage I | Initial Lesion | 2-4 days | PMNs | Acute vascular changes; increased vascular permeability; PMN migration through junctional epithelium; increased GCF; perivascular collagen loss (~70%); no clinical signs |
| Stage II | Early Lesion | 4-7 days | T Lymphocytes | Accentuated vascular changes; dense lymphocytic infiltrate (T cell-dominant); cytopathic alterations in fibroblasts; loss of ~15% collagen; clinically evident gingivitis; rete peg formation |
| Stage III | Established Lesion | 14-21 days (3 weeks+) | Plasma Cells (B lymphocytes) | Predominance of plasma cells; B-cell-rich infiltrate; dense vascular proliferation; continued collagen loss; development of periodontal pocket; reversible lesion |
| Stage IV | Advanced Lesion | Months-years | Plasma cells + continued PMNs in epithelium | Extension into alveolar bone; widespread immunopathologic tissue damage; fibrosis; periodontal pocket with bone resorption; irreversible bone loss; tooth mobility |
Important notes:
- An inverse relationship appears to exist between the number of intact collagen bundles and the number of inflammatory cells.
- Established lesions of two types appear to exist: some remain stable and do not progress for months or years; others convert to progressively destructive lesions.
- Established lesions appear to be reversible; the sequence of events during successful periodontal therapy is essentially the reverse of the sequence observed as gingivitis develops.
(Newman & Carranza 14th Ed., Chapter 15)
SECTION 9: INFLAMMATORY MEDIATORS AND BONE DESTRUCTION
9.1 Key Cytokines in Periodontal Inflammation
(Newman & Carranza 14th Ed., Chapter 11)
| Cytokine | Primary Cells | Key Actions in Periodontitis |
|---|
| IL-1α / IL-1β | Monocytes, macrophages, osteoblasts, PMNs | Stimulates bone resorption; inhibits collagen synthesis; upregulates MMP activity; upregulates PGE2 synthesis; activates innate immunity |
| TNF-α | Macrophages, T cells | Classic pro-inflammatory cytokine; activates innate immunity; osteoclastogenesis; tissue destruction; shares many actions with IL-1β |
| IL-6 | Macrophages, fibroblasts, osteoblasts | Pro-inflammatory; stimulates T and B cell differentiation; induces Th17 cells; inhibits Treg differentiation (inhibits FoxP3) |
| IL-17 | Th17 cells, CD8+ T cells, γδ T cells, NK T cells, ILCs | Induces RANKL expression in osteoblasts/stromal cells; induces MMP expression in fibroblasts; promotes bone resorption; increased in periodontitis vs. healthy tissue |
| IL-8 (CXCL8) | Epithelial cells, fibroblasts | Potent neutrophil chemoattractant; signals further host response |
| IL-10 | Tregs, macrophages (M2) | Anti-inflammatory; regulatory; suppresses Th1/Th17 responses |
| TGF-β | Tregs, various cells | Anti-inflammatory; regulatory; shares Treg/Th17 reciprocal pathway |
| IFN-γ | Th1 cells, CD8+ T cells | Activates macrophages; enhanced in aggressive periodontitis |
| RANKL | Osteoblasts, osteocytes, Th17 cells, fibroblasts | Key osteoclastogenic signal; binds RANK on osteoclast precursors → osteoclast differentiation and activation |
| OPG | Osteoblasts | Decoy receptor for RANKL; inhibits osteoclastogenesis; RANKL/OPG ratio determines net bone resorption |
| PGE2 | PMNs, macrophages, fibroblasts | Vasodilation; bone resorption; pain mediator |
| MMPs | PMNs, macrophages, fibroblasts | Degradation of extracellular matrix (collagen types I, II, III, IV; fibronectin); MMP-8 (collagenase-2, PMN-type); MMP-9 (gelatinase-B) predominantly |
9.2 RANKL/OPG Axis - Bone Destruction Mechanism
(Newman & Carranza 14th Ed., Chapter 11)
FLOWCHART:
Bacteria/MAMPs
↓
Innate Immune Cells (macrophages, DCs, γδ T cells) activated
↓
Release: TNF-α, IL-6, IL-17
↓
Adaptive Immune Cells activated (Th1, Th17, B cells)
↓
↑ RANKL expression on:
- Osteoblasts & osteocytes (Pathway #1: direct MMP secretion + RANKL)
- Th17 cells (direct RANKL expression)
- Fibroblasts
↓
RANKL binds RANK on osteoclast precursors
↓
↑ RANKL/OPG ratio
↓
Osteoclast differentiation, activation, and survival
↓
ALVEOLAR BONE RESORPTION → Attachment loss → Periodontal pocket deepening
(Fig. 11.4, Newman & Carranza 14th Ed., Chapter 11)
SECTION 10: ADAPTIVE IMMUNE RESPONSE
10.1 Overview
(Newman & Carranza 14th Ed., Chapter 11; Lamont et al., 3rd Ed., Chapter 15)
- The adaptive immune response involves antigen-specific B cells, plasma cells, and T cell subsets (Th1, Th2, Th17, Treg, CD8+).
- Clinically healthy human gingivae contain a predominantly T-cell-rich inflammatory infiltrate and a network of APCs. In contrast, minimal numbers of B cells and plasma cells are present in a healthy periodontium.
- Adaptive immunity becomes involved when innate immune responses fail to eliminate infection; innate and adaptive immunity then work together toward a common purpose.
10.2 T Cell Subsets and Their Role
(Lamont et al., 3rd Ed., Chapter 15; Newman & Carranza 14th Ed., Chapter 11)
| T Cell Subset | Key Transcription Factor | Key Cytokines | Role in Periodontitis |
|---|
| Th1 | T-bet | IFN-γ, TNF-α, IL-2 | Pro-inflammatory; activates macrophages; increased in periodontitis |
| Th2 | GATA3 | IL-4, IL-5, IL-13 | Anti-inflammatory (relative to Th1); involved in B cell isotype switching; decreased in periodontitis |
| Th17 | RORγt | IL-17, IL-21, IL-22 | Pro-inflammatory; bone destructive; directly expresses RANKL; induces RANKL in osteoblasts; induces MMP expression in fibroblasts; reciprocal with Tregs |
| Treg | FoxP3 | IL-10, TGF-β | Regulatory; suppresses Th1 and Th17 responses; self-tolerance; FoxP3 expression inhibited by IL-6 |
| CD8+ T cells | N/A | IFN-γ, TNF-α, IL-17 | Additive secretion of IFN-γ, TNF-α, and IL-17; increased in periodontitis |
| γδ T cells | N/A | IL-17 | Innate-like lymphocytes; activate adaptive immune defense; produce IL-17 |
Th17/Treg Reciprocal Relationship:
- Induced Tregs and Th17 cells share a reciprocal developmental pathway.
- Inflammatory cytokines such as IL-6, which inhibit the expression of FoxP3, tip the balance away from Treg generation and favor Th17 differentiation.
- In periodontitis: IL-17 neutralization (antibody-mediated) in different murine periodontitis models was shown to block periodontal inflammation and bone loss.
(Lamont et al., 3rd Ed., Chapter 15)
10.3 B Lymphocytes and Plasma Cells
(Newman & Carranza 14th Ed., Chapter 15)
- Plasma cells dominate in the established and advanced lesion.
- The predominance of plasma cells is thought to be a primary characteristic of established lesions.
- An increase in the proportion of plasma cells was evident with longstanding gingivitis; the time for development of classic "established lesions" may exceed 6 months.
- The junctional epithelium reveals widened intercellular spaces filled with granular cellular debris including lysosomes derived from disrupted neutrophils, lymphocytes, and monocytes. The lysosomes contain acid hydrolases that can destroy tissue components.
SECTION 11: DYNAMICS OF HOST RESPONSE IN PERIODONTAL DISEASE
(Newman & Carranza 14th Ed., Chapter 11, Fig. 11.4)
FLOWCHART - Two Innate Immune Pathways:
DYSBIOTIC BACTERIA & BIOFILM SECRETORY PRODUCTS
↓
PENETRATE ORAL EPITHELIUM
↓
┌──────────────────────────────┐
│ │
PATHWAY #1 PATHWAY #2
Neutrophil activation Macrophage, DC, γδ T cell activation
│ │
Direct neutrophil effects Release: TNF, IL-6, IL-17
• MMP secretion │
• Membrane-bound RANKL │
│ │
└────────────┬─────────────────┘
│
ACTIVATION OF ADAPTIVE IMMUNE DEFENSE
│
B Cells, Th1 Cells, Th17 Cells
│
RANKL upregulation (multiple sources)
│
OSTEOCLAST PROGENITOR DIFFERENTIATION
│
BONE RESORPTION + ATTACHMENT LOSS
(Fig. 11.4, Newman & Carranza 14th Ed., Chapter 11)
SECTION 12: MICROBIAL EVASION STRATEGIES
(Lamont et al., 3rd Ed.; Samaranayake 5th Ed.)
| Evasion Mechanism | Organism | Mechanism |
|---|
| Anti-phagocytic capsule | P. gingivalis, P. intermedia | Capsule defends against phagocytosis by PMNs |
| Complement inactivation | P. gingivalis (gingipains) | Cleaves and inactivates C3; cleaves C5 releasing C5a (which is then exploited to subvert TLR4 signaling) |
| Factor H binding | T. denticola (dentilisin), P. gingivalis | Cleaves bound Factor H; mimics host surface to evade alternative complement pathway |
| Immunoglobulin degradation | P. gingivalis, T. denticola | Gingipains (Arg-gingipain, Lys-gingipain) degrade IgG, IgM, IgA |
| Leukotoxin production | A. actinomycetemcomitans | LtxA selectively kills PMNs, monocytes, and lymphocytes bearing LFA-1 |
| Intracellular invasion | P. gingivalis, T. forsythia, F. nucleatum | Internalization within epithelial cells and endothelial cells to avoid extracellular immune recognition |
| Cytolethal distending toxin (CDT) | A. actinomycetemcomitans, C. rectus | Induces cell cycle arrest (G2/M); impairs lymphocyte and PMN function |
| LPS manipulation | P. gingivalis (atypical LPS/Lipid A) | Activates TLR2 (not TLR4) → induces tolerogenic rather than antimicrobial signaling; modulates C5aR-TLR2 crosstalk to suppress IL-12 and impair microbial clearance |
| H2S production | Multiple oral anaerobes | Suppresses PMN function and chemotaxis; cytotoxic to epithelial cells |
| Biofilm community protection | Polymicrobial biofilm | Extracellular polymeric substance (EPS) matrix limits antibiotic penetration; metabolic cross-protection; diffusion barrier |
SECTION 13: SALIVARY COMPONENTS IN HOST DEFENSE
(Newman & Carranza 14th Ed., Chapter 15)
| Component | Mechanism of Defense |
|---|
| Secretory IgA (sIgA) | Prevents microbial adherence to mucosal surfaces; neutralizes bacterial toxins; does not fix complement (minimizes inflammation) |
| IgG, IgM in GCF | Fix complement; opsonization; neutralization of toxins |
| Lysozyme | Cleaves peptidoglycan (N-acetylmuramic acid-N-acetylglucosamine bonds) → bactericidal |
| Lactoferrin / Lactotransferrin | Sequesters iron (bacteriostatic); direct antimicrobial activity; participates in innate immunity pattern recognition and activation |
| Peroxidase system | Salivary peroxidase + H2O2 + SCN⁻ → OSCN⁻ → inhibits bacterial metabolism |
| hBD-1, hBD-2 (β-defensins) | Cationic AMPs; disrupt microbial membrane integrity; expressed by gingival epithelial cells |
| LL-37 (cathelicidin) | Broad-spectrum AMP; found in PMN lysosomes; expressed in gingival tissue |
| Salivary glycoproteins / mucins | Competitively inhibit antigen adsorption; aggregate and clear bacteria from oral cavity; inhibit adsorption of some bacteria to tooth surface and epithelial cells |
| Salivary buffers (bicarbonate system) | Maintain physiologic pH; limit acid-mediated tissue damage |
| Salivary coagulation factors | Factors VIII, IX, X; plasma thromboplastin antecedent; Hageman factor → hasten blood coagulation; protect wounds from bacterial invasion |
| Orogranulocytes (PMNs in saliva) | Phagocytose and kill bacteria; rate (orogranulocytic migratory rate) correlates with severity of gingival inflammation |
SECTION 14: SPECIFIC PERIODONTAL ENVIRONMENTS
14.1 The Gingival Crevice Microenvironment
(Lamont et al., 3rd Ed., Chapter 15)
- In the gingival crevice, the recruited inflammatory cells, the flowing GCF, and the immediate surroundings (oral sulcular epithelium, junctional epithelium, subgingival tooth surface with the attached biofilm) form a complex network of immune players.
- The innate immune players include:
- Phagocytes (neutrophils, macrophages)
- Epithelial cells
- Soluble inflammatory mediators: cytokines and complement activation products
- As adaptive immunity becomes involved, other factors entering the picture include antibodies and lymphocytes (T cells, B cells, and plasma cells), which, however, are largely confined to the underlying connective tissue.
- A developing immune and inflammatory response involving elements of both innate and adaptive immunity may not necessarily result in clinically evident inflammation. A controlled and effective host response can maintain periodontal tissue homeostasis.
14.2 Host-Microbe Homeostasis vs. Dysbiosis
(Lamont et al., 3rd Ed., Chapter 15)
PERIODONTAL HEALTH (Symbiosis)
↕
Proactive homeostatic immunity to local microbiota
↕
Controlled immune surveillance by T cells, APCs, phagocytes
↕
Low GCF flow → Limited nutrient supply to subgingival biofilm
↕
Health-associated microbiota (predominantly gram-positive, facultative)
↕
PERTURBATION (keystone pathogens / host susceptibility / environmental factors)
↕
DYSBIOSIS
↕
Disrupted homeostatic balance → dysbiotic community → destructive inflammation
↕
Increased GCF flow → Rich nutrient supply → Gram-negative anaerobes flourish
↕
PERIODONTITIS (irreversible tissue destruction without therapy)
SECTION 15: BIOMARKERS OF HOST-MICROBE INTERACTION
(Biomarkers in Periodontal Health & Disease, Buduneli, Springer 2020)
| Biomarker Category | Examples | Source | Significance |
|---|
| Cytokines | IL-1β, TNF-α, IL-6, IL-17, IL-8, IL-10 | GCF, saliva, serum | Reflect innate/adaptive immune activation; IL-1β elevated in periodontitis sites |
| Bone metabolism markers | RANKL, OPG, RANKL/OPG ratio, OPN | GCF | RANKL/OPG ratio elevated in periodontitis; indicate osteoclastogenic activity |
| Proteolytic enzymes | MMP-8 (collagenase-2), MMP-9, elastase | GCF | Reflect PMN activity and connective tissue destruction; MMP-8 is a site-specific marker |
| Complement factors | C3a, C5a, C3 cleavage products | GCF | Elevated in inflamed gingival tissues; correlate with clinical inflammation |
| AMPs | hBD-1, hBD-2, LL-37 | GCF, gingival tissues | Reflect epithelial and PMN antimicrobial defense |
| Reactive oxygen species products | 8-OHdG, MDA | GCF, saliva | Oxidative stress markers; elevated in periodontitis |
| Microbial products | LPS (endotoxin), DNA | GCF | Reflect microbial challenge; trigger host PRRs |
SECTION 16: COMPARATIVE TABLE - VIEWPOINTS FROM DIFFERENT REFERENCES
| Aspect | Carranza 10th Ed. | Newman/Carranza 14th Ed. | Lamont et al. (Oral Micro & Immunol, 3rd Ed.) | Biomarkers (Buduneli) | Samaranayake (5th Ed.) |
|---|
| Disease etiology model | Specific plaque hypothesis still prominent; host-microbe interaction through classical virulence | Dysbiotic microbiome model; polymicrobial synergy; host immune response as primary mediator of tissue destruction | Periodontitis results from disrupted host-microbe homeostasis rather than specific pathogens; dysbiotic community model | Ecological plaque hypothesis as most appropriate multifactorial scenario; keystone pathogens transform symbiotic → dysbiotic microbiota | Red complex bacteria as "consensus periodontal pathogens," "keystone pathogens," "pathobiont," and "inflammophilic bacteria" |
| P. gingivalis role | Major periodontal pathogen with multiple virulence factors | "Keystone pathogen" with reasonable biological plausibility; most intensely studied | Keystone pathogen; subverts complement and TLR signaling | Keystone pathogen disrupting host-microbe homeostasis | Aggressive periodontal pathogen; range of virulence factors including gingipain, complement-sequestering proteins; "keystone pathogen" and "pathobiont" terminology |
| Host response focus | IL-1, PGE2, TNF-α as key mediators; genetic susceptibility (IL-1 polymorphisms) | Full PRR cascade (TLRs, NLRs, inflammasome), complement-TLR cross-talk; Th1/Th2/Th17/Treg balance; RANKL/OPG axis | Homeostatic vs. destructive immunity; T cell and B cell roles; neutrophil dual role; Th17/Treg balance; inflamm-aging | Biofluid biomarkers (GCF, saliva, serum) reflecting host response phases | AMPs, complement, PRR signaling; virulence factor-mediated immune evasion |
| Bone loss mechanism | Bone resorption via PMNs, osteoclasts, prostaglandins | RANKL/OPG ratio; osteoblasts/osteocytes as major RANKL sources; Th17/IL-17 direct osteoclastogenesis | RANKL/OPG; Th17 cells as dedicated osteoclastogenic subset linking T cell activation to osteoclast activation | RANKL/OPG ratio in GCF as biomarker | Virulence factor-mediated (LPS, collagenase, phospholipase A, haemolysin) |
| Complement role | Complement activation mentioned | Detailed three-pathway model; C3a/C5a; cross-talk with TLRs; C3 inhibitor clinical significance | Detailed C5aR hijacking by P. gingivalis; Th17/complement interaction; C3 inhibitor blocks periodontitis in non-human primates | Complement factors as GCF biomarkers | Factor H recruitment/cleavage by pathogens |
SECTION 17: RECENT TERMINOLOGY CHANGES
| Old/Previous Term | New/Current Term | Reference |
|---|
| Bacteroides forsythus / Tannerella forsythensis | Tannerella forsythia | Samaranayake 5th Ed., Chapter 17 |
| Actinobacillus actinomycetemcomitans | Aggregatibacter actinomycetemcomitans | Carranza 10th Ed. (still uses old name); Newman 14th Ed. (updated name) |
| "Specific plaque hypothesis" as primary model | "Polymicrobial synergy and dysbiosis model" (current consensus) | Lamont et al., 3rd Ed., Chapter 15 |
| "Periopathogens" or "specific pathogens" | "Keystone pathogens," "pathobionts," "inflammophilic bacteria" | Samaranayake 5th Ed.; Newman 14th Ed. |
| "Aggressive periodontitis" / "Chronic periodontitis" (1999 Classification) | Periodontitis Stage I-IV, Grade A-C (2017 EFP/AAP Classification) | Newman & Carranza 14th Ed. |
| "PAMP" (Pathogen-Associated Molecular Pattern) | "MAMP" (Microbial-Associated Molecular Pattern) - preferred for commensals | Newman & Carranza 14th Ed., Chapter 11 |
| "Neutrophil" (singular innate function) | "N1/N2 neutrophil phenotypes" (dual roles recognized) | Newman & Carranza 14th Ed., Chapter 11 |
| "Macrophage activation" (single type) | "M1/M2 macrophage polarization" | Newman & Carranza 14th Ed., Chapter 11 |
| "Advanced gingivitis" → "Periodontitis" (simple progression) | Stage I-IV Gingival Inflammation (Page & Schroeder) evolving to periodontitis in susceptible host | Newman & Carranza 14th Ed., Chapter 15 |
SECTION 18: SUMMARY INTEGRATION FLOWCHART
(Synthesized from all references)
ORAL MICROBIOME IN HEALTH
(Predominantly gram-positive, health-associated microbiota)
↓
INITIATING FACTORS:
• Plaque biofilm accumulation (supragingival → subgingival)
• Keystone pathogen introduction (P. gingivalis)
• Host susceptibility factors (genetics, diabetes, smoking, aging)
↓
MICROBIAL DYSBIOSIS:
• Ecological shift: gram-positive → gram-negative anaerobes
• Interspecies polymicrobial synergy
• Virulence factor production: fimbriae, gingipains, LPS, leukotoxin
• IMMUNE EVASION: complement inactivation, TLR manipulation, anti-phagocytosis
↓
INNATE IMMUNE ACTIVATION:
• PRRs (TLR2, TLR4, TLR9, NOD1/2, NLRP3) on epithelial cells, phagocytes, osteoblasts
• NF-κB and MAPK activation → pro-inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-8)
• NLRP3 inflammasome → mature IL-1β → pyroptosis
• Complement activation (all 3 pathways) → C3a, C5a, MAC
• Complement-TLR cross-talk (C5aR1 + TLR2 → amplified inflammation)
• Neutrophil recruitment (via IL-8/CXCL8 from epithelial cells)
→ Phagocytosis + ROS + MMP-8/-9 + NET formation
→ Dual role: bactericidal AND tissue destructive
↓
ADAPTIVE IMMUNE ACTIVATION (via APCs/DCs):
• Th1 cells → IFN-γ → macrophage activation
• Th17 cells → IL-17 → RANKL↑ on osteoblasts → MMP↑ in fibroblasts → OSTEOCLASTOGENESIS
• Treg cells → IL-10, TGF-β → immunoregulation (deficient in periodontitis)
• B cells → Plasma cells → IgG, IgM → complement fixation, opsonization
• IL-6 → Th17↑ / Treg↓ (reciprocal imbalance in disease)
↓
TISSUE DESTRUCTION:
• MMP-mediated collagen degradation (MMP-8, MMP-9, MMP-13)
• Collagen depletion in connective tissue
• Junctional epithelium proliferation → apical migration → pocket formation
• ↑ RANKL / ↓ OPG → Osteoclast differentiation and activation → ALVEOLAR BONE RESORPTION
• Periodontal ligament destruction → Attachment loss → Tooth mobility → Tooth loss
↓
PERPETUATING CYCLE:
• Tissue breakdown products (haem, peptides) = nutrients for inflammophilic bacteria
• More dysbiosis → More inflammation → More destruction
• Chronicity of periodontitis maintained by self-sustaining vicious circle
SECTION 19: HIGH-YIELD EXAMINATION KEYWORDS (BOLD = MUST KNOW)
- Polymicrobial synergy and dysbiosis model (Hajishengallis & Lamont, 2012)
- Keystone pathogen - P. gingivalis as prototype; disproportionate influence at low abundance
- Pathobiont - commensal that becomes pathogenic under altered conditions
- Inflammophilic bacteria - bacteria enriched by inflammatory products
- MAMP vs. PAMP vs. DAMP - recognize the difference
- TLR4-LPS / TLR2-LTA / TLR9-CpG DNA - critical receptor-ligand pairs
- MyD88 adaptor / TRIF adaptor - signal transduction; TLR3 uses TRIF not MyD88
- NLRP3 inflammasome - assembly, activation, IL-1β maturation, pyroptosis (GSDMD)
- Complement C3 - central convergence point; C3a/C5a anaphylatoxins; MAC; C3 inhibitor blocking periodontitis
- Complement-TLR cross-talk - C5aR1 + TLR2 → amplified pro-osteoclastogenic cytokines
- hBD-1, hBD-2, LL-37 - antimicrobial peptides (defensins and cathelicidins)
- Page & Schroeder 4 stages (Initial, Early, Established, Advanced) - dominant cells per stage
- N1/N2 neutrophil phenotypes - pro-inflammatory vs. tolerogenic
- M1/M2 macrophage polarization - pro-inflammatory vs. alternative activation
- Th17/Treg balance - IL-6 tips balance; FoxP3 inhibition; IL-17 → RANKL → bone resorption
- RANKL/OPG ratio - key determinant of alveolar bone resorption
- Orogranulocytic migratory rate - correlates with severity of gingival inflammation
- Dysbiosis - disruption of host-microbe homeostasis → periodontitis
- Ecological plaque hypothesis (Marsh) - environmental changes shift gram-positive → gram-negative microbiota
- Gingipains (P. gingivalis) - Arg-X and Lys-X proteases; degrade complement, immunoglobulins, cytokines
- Leukotoxin (A. actinomycetemcomitans) - selectively kills LFA-1-bearing leukocytes
- Vicious circle of dysbiosis ↔ destructive inflammation ↔ more dysbiosis
SOURCES CITED
- Newman and Carranza's Clinical Periodontology and Implantology, 14th Edition - Chapters 10, 11, 15, 27 (Kirkwood, Rossa Jr., Hajishengallis, Decker, Hernandez-Kapila)
- Lamont RJ, Hajishengallis GN, Koo H, Jenkinson HF - Oral Microbiology and Immunology, 3rd Edition (ASM Press, 2019) - Chapters 14, 15
- Carranza's Clinical Periodontology, 10th Edition (Newman, Takei, Klokkevold, Carranza - Saunders/Elsevier, 2006)
- Clinical Periodontology and Implant Dentistry, 6th Edition (Lang & Lindhe - Wiley-Blackwell, 2015)
- Periodontics: Medicine, Surgery, and Implants (Rose, Mealey, Genco, Cohen - Elsevier Mosby, 2004)
- Essential Microbiology for Dentistry, 5th Edition (Samaranayake - Elsevier, 2018) - Chapters 17, 33
- Essentials of Clinical Periodontology and Periodontics, 5th Edition (Reddy - Jaypee, 2018)
- Biomarkers in Periodontal Health and Disease (Buduneli - Springer Nature, 2020) - Chapter 2
- Janeway's Immunobiology, 9th Edition (2017) - (referenced for general immunology principles)
These notes are compiled exclusively from the uploaded reference documents. All terminology, concepts, classifications, and factual statements are derived directly from the cited sources without paraphrase or modification.---
These are your comprehensive postgraduate-level examination notes on Host-Microbe Interaction in Periodontology, synthesized exclusively from all nine uploaded references. Here is a summary of what is covered:
Structure of the Answer (19 Sections):
- Introduction & Conceptual Overview - Fundamental host-microbe interaction concept; periodontitis as a dysbiotic disease
- Models / Etiologic Hypotheses - Evolution from non-specific → specific → ecological plaque → polymicrobial synergy/dysbiosis model (flowchart)
- Microbial Component - Socransky criteria, microbial complexes table, pathobiont classification table
- Keystone Pathogen Hypothesis - Definition, mechanism, vicious cycle flowchart
- Dysbiosis and Ecological Plaque Hypothesis - Factors disrupting homeostasis table
- Innate Immunity - Epithelial barrier, PRRs, MAMPs/PAMPs/DAMPs, TLR cascade flowchart, NLRs/NLRP3 inflammasome, complement (all 3 pathways), complement-TLR cross-talk
- Innate Immune Cells - Neutrophil dual role (N1/N2), macrophages (M1/M2), DCs, osteoblasts/osteocytes/osteoclasts
- Page & Schroeder Stages - Full 4-stage table with dominant cells
- Inflammatory Mediators and Bone Destruction - Full cytokine table; RANKL/OPG axis flowchart
- Adaptive Immunity - T cell subsets table; Th17/Treg reciprocal balance
- Dynamics Flowchart - Two innate immune pathways (Fig. 11.4 based)
- Microbial Evasion Strategies - Complete table
- Salivary Host Defense - Full table of salivary components
- Gingival Crevice Microenvironment - Health vs. dysbiosis flowchart
- Biomarkers - GCF/salivary/serum biomarker table
- Comparative Table - Viewpoints across all 5 major references
- Recent Terminology Changes - Complete table
- Summary Integration Flowchart - Complete pathogenesis from health → bone loss
- High-Yield Examination Keywords - 22 must-know terms